This inventor holds 9 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Wista Laboratories Ltd., Knoll Aktiengesellschaft, Abbott Gmbh & Co Kg. Active years: 1998-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nottingham, GB (1998 - 2015)
- Old Aberdeen, GB (2016)
- West Bridgeford, GB (2018 - 2024)
Company Filing History:
6 out of 59 
2 out of 84 
1 out of 140 
Years Active: 1998-2024
Title: The Innovative Mind of Karrar Ahmad Khan
Introduction: Karrar Ahmad Khan, an accomplished inventor residing in West Bridgeford, GB, has made significant contributions to the field of pharmaceutical innovation. With a portfolio of nine patents, Khan's work primarily focuses on novel compounds that hold promise for medical applications.
Latest Patents: Among his latest patents, Karrar has developed phenothiazine diaminium salts and their uses. These compounds, encompassed by a general formula, represent a breakthrough in pharmaceutical formulations, offering methods and applications for the treatment of various diseases. The innovative nature of these compounds and their potential therapeutic uses underlie Khan's commitment to advancing healthcare solutions.
Career Highlights: Karrar Ahmad Khan has built an impressive career in the pharmaceutical industry, having worked with notable companies such as Wista Laboratories Ltd. and Knoll Aktiengesellschaft. His dedication to research and development has enabled him to explore new avenues in drug formulation and therapeutic strategies.
Collaborations: Throughout his career, Karrar has collaborated with remarkable colleagues, including Scott Clunas and John Mervyn David Storey. These partnerships have fostered an environment of innovation, contributing to the successful development of various patented technologies.
Conclusion: Karrar Ahmad Khan exemplifies the spirit of innovation through his extensive patent portfolio and impactful collaborations. His work in developing phenothiazine diaminium salts illustrates his commitment to advancing scientific knowledge and improving patient outcomes. With a strong foundation in research and a dedication to innovation, Karrar continues to inspire future generations of inventors and scientists.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile